Five things you need to know about the coronavirus pandemic this Saturday morning.
Here are five things you need to know about the coronavirus pandemic this Saturday morning. We'll have another update for you tomorrow.book their coronavirus booster jabs
a month in advance from Monday. The change comes as part of government efforts to speed up the rollout of a third vaccine dose to the over-50s and vulnerable people. The current system means you cannot book an appointment until at least six months after your second. But the government said the coming winter was going to be "challenging" and vaccines were the best way to protect people.
, which has left him unable to play after contracting the virus more than a year ago. Finlay Macnab says he suffers from "extreme fatigue" and feels like he has played a 90-minute game even after just walking up the stairs. The 20-year-old AFC Wimbledon midfielder also explained he struggled with keeping his heart rate down, with even the act of standing causes it to spike.
. This means the jab will join the existing list of basic vaccinations required to have in childhood. The country has signed a deal with pharmaceutical company Pfizer to begin the process of vaccinating under-12s from March next year. The deal will see the country received 3.5 million doses, of which 1.5 million will be used to vaccinate children aged five to 11.
The weekday morning coronavirus briefing is being paused for two weeks to tell you five things you need to know about the COP26 climate summit.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
COVID-19: Gene that doubles risk of respiratory failure from COVID identified by Oxford University scientistsCrucially, those carrying the gene respond normally to vaccines because it does not affect the immune system, and so jabs should 'cancel out' the increased risk.
Lire la suite »
New COVID-19 pill cut hospital, death risk by 90%Pfizer Inc released preliminary clinical trial results on Friday showing its experimental antiviral pill reduced hospitalization and death rates by 89%.
Lire la suite »
Covid-19 pill approved in UK and post-lockdown rebound in carbon emissions➡️ UK approves first pill designed to treat Covid ➡️ Carbon emissions show rapid rebound after Covid dip ➡️ Sainsbury's says supply issues won't hit Christmas Here's our evening coronavirus update
Lire la suite »
'Stop COVID-19 hanging around': Campaign encourages people to open windows over ChristmasWith people spending more time socialising indoors in winter months, the campaign encourages people to open windows for 10 minutes each hour, highlighting the importance of ventilation.
Lire la suite »